C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection
Objectives: We assessed C-reactive protein (CRP) and plasma albumin (PA) kinetics to evaluate community-acquired bloodstream infection (CA-BSI) patients’ 1-year outcomes. Methods: Population-based study, with CRP and PA measurements on day 1 (D1) and D4. Relative CRP variations in relation to D1 CRP...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | International Journal of Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S120197122030196X |
| _version_ | 1818310684111273984 |
|---|---|
| author | Pedro Póvoa Olav Sivertsen Garvik Pernille Just Vinholt Court Pedersen Thøger Gorm Jensen Hans Jørn Kolmos Annmarie Touborg Lassen Kim Oren Gradel |
| author_facet | Pedro Póvoa Olav Sivertsen Garvik Pernille Just Vinholt Court Pedersen Thøger Gorm Jensen Hans Jørn Kolmos Annmarie Touborg Lassen Kim Oren Gradel |
| author_sort | Pedro Póvoa |
| collection | DOAJ |
| description | Objectives: We assessed C-reactive protein (CRP) and plasma albumin (PA) kinetics to evaluate community-acquired bloodstream infection (CA-BSI) patients’ 1-year outcomes. Methods: Population-based study, with CRP and PA measurements on day 1 (D1) and D4. Relative CRP variations in relation to D1 CRP value were evaluated (CRP-ratio). Patients were classified as fast response, slow response, non-response, and biphasic response. Results: A total of 935 patients were included. At D4, the CRP-ratio was lower in survivors on D365 in comparison with D4–D30 non-survivors and D30–D365 non-survivors (p < 0.001). In comparison with fast response patients, non-response and biphasic response patients had 2.74 and 5.29 increased risk, respectively, of death in D4–D30 and 2.77 and 3.16 increased risk, respectively, of death in D31–D365. PA levels remained roughly unchanged from D1–D4, but lower D1 PA predicted higher short and long-term mortality (p < 0.001). The discriminative performance of the CRP-ratio and D1 PA to identify patients with poor short and long-term mortality after adjustments was acceptable (AUROC = 0.79). Conclusions: Serial CRP measurements at D1 and D4 after CA-BSI is clinically useful to identify patients with poor outcome. Individual patterns of CRP-ratio response with PA at D1 further refine our ability of predicting short or long-term mortality. |
| first_indexed | 2024-12-13T07:49:58Z |
| format | Article |
| id | doaj.art-bb1a18dc912b418faa263b1f5ccb2858 |
| institution | Directory Open Access Journal |
| issn | 1201-9712 |
| language | English |
| last_indexed | 2024-12-13T07:49:58Z |
| publishDate | 2020-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | International Journal of Infectious Diseases |
| spelling | doaj.art-bb1a18dc912b418faa263b1f5ccb28582022-12-21T23:54:43ZengElsevierInternational Journal of Infectious Diseases1201-97122020-06-01955058C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infectionPedro Póvoa0Olav Sivertsen Garvik1Pernille Just Vinholt2Court Pedersen3Thøger Gorm Jensen4Hans Jørn Kolmos5Annmarie Touborg Lassen6Kim Oren Gradel7Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, CHLO, Estrada do Forte do Alto do Duque, 1449-005 Lisbon, Portugal; NOVA Medical School, CHRC, New University of Lisbon, Campo dos Mártires da Pátria, 1169-056 Lisbon, Portugal; Center for Clinical Epidemiology, Odense University Hospital, and Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Kløvervænget 30, Entrance 216, Ground Floor, 5000 Odense C, DenmarkCenter for Clinical Epidemiology, Odense University Hospital, and Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Kløvervænget 30, Entrance 216, Ground Floor, 5000 Odense C, DenmarkDepartment of Clinical Biochemistry and Pharmacology, Odense University Hospital, Sdr. Boulevard 29, Entrance 40, 5000 Odense C, DenmarkDepartment of Infectious Diseases, Odense University Hospital, Sdr. Boulevard 29, Entrance 20, 5000 Odense C, DenmarkDepartment of Clinical Microbiology, Odense University Hospital, J.B. Winsløws Vej 21, 2nd Floor, 5000 Odense C, DenmarkDepartment of Clinical Microbiology, Odense University Hospital, J.B. Winsløws Vej 21, 2nd Floor, 5000 Odense C, DenmarkDepartment of Emergency Medicine, Odense University Hospital, Kløvervænget 25, Entrance 63-65, 5000 Odense C, DenmarkCenter for Clinical Epidemiology, Odense University Hospital, and Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Kløvervænget 30, Entrance 216, Ground Floor, 5000 Odense C, Denmark; Corresponding author at: Center for Clinical Epidemiology, Odense University Hospital, and Research Unit of Clinical Epidemiology, Institute of Clinical Research, University of Southern Denmark, Kløvervænget 30, Entrance 216, Ground Floor, 5000 Odense C, Denmark.Objectives: We assessed C-reactive protein (CRP) and plasma albumin (PA) kinetics to evaluate community-acquired bloodstream infection (CA-BSI) patients’ 1-year outcomes. Methods: Population-based study, with CRP and PA measurements on day 1 (D1) and D4. Relative CRP variations in relation to D1 CRP value were evaluated (CRP-ratio). Patients were classified as fast response, slow response, non-response, and biphasic response. Results: A total of 935 patients were included. At D4, the CRP-ratio was lower in survivors on D365 in comparison with D4–D30 non-survivors and D30–D365 non-survivors (p < 0.001). In comparison with fast response patients, non-response and biphasic response patients had 2.74 and 5.29 increased risk, respectively, of death in D4–D30 and 2.77 and 3.16 increased risk, respectively, of death in D31–D365. PA levels remained roughly unchanged from D1–D4, but lower D1 PA predicted higher short and long-term mortality (p < 0.001). The discriminative performance of the CRP-ratio and D1 PA to identify patients with poor short and long-term mortality after adjustments was acceptable (AUROC = 0.79). Conclusions: Serial CRP measurements at D1 and D4 after CA-BSI is clinically useful to identify patients with poor outcome. Individual patterns of CRP-ratio response with PA at D1 further refine our ability of predicting short or long-term mortality.http://www.sciencedirect.com/science/article/pii/S120197122030196XCommunity-acquired bloodstream infectionsC-reactive proteinAlbuminMortalityPrognosis |
| spellingShingle | Pedro Póvoa Olav Sivertsen Garvik Pernille Just Vinholt Court Pedersen Thøger Gorm Jensen Hans Jørn Kolmos Annmarie Touborg Lassen Kim Oren Gradel C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection International Journal of Infectious Diseases Community-acquired bloodstream infections C-reactive protein Albumin Mortality Prognosis |
| title | C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection |
| title_full | C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection |
| title_fullStr | C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection |
| title_full_unstemmed | C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection |
| title_short | C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection |
| title_sort | c reactive protein and albumin kinetics after antibiotic therapy in community acquired bloodstream infection |
| topic | Community-acquired bloodstream infections C-reactive protein Albumin Mortality Prognosis |
| url | http://www.sciencedirect.com/science/article/pii/S120197122030196X |
| work_keys_str_mv | AT pedropovoa creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT olavsivertsengarvik creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT pernillejustvinholt creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT courtpedersen creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT thøgergormjensen creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT hansjørnkolmos creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT annmarietouborglassen creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection AT kimorengradel creactiveproteinandalbuminkineticsafterantibiotictherapyincommunityacquiredbloodstreaminfection |